Holen Sie sich die Stockscreener-App
1.04
0.70%
-0.0073
Handel nachbörslich:
1.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
50.43%
0.7795
|
1.5725 | 2.1989 | 1.9644 | 2.295 |
| Operating Income/Loss |
50.43%
-0.7795
|
-1.5725 | -2.9949 | -1.9644 | -2.295 |
| Nonoperating Income/Loss |
73.65%
-0.031
|
-0.1175 | -0.8176 | -0.1186 | -0.0142 |
| Income/Loss From Equity Method Investments |
21.17%
-0.0248
|
-0.0314 | -0.653 | -0.0542 | -0.0449 |
| Income/Loss From Continuing Operations Before Tax |
52.04%
-0.8105
|
-1.6899 | -3.8124 | -2.0829 | -2.3092 |
| Net Income/Loss |
52.04%
-0.8105
|
-1.6899 | -3.8124 | -2.0835 | -2.3328 |
| Attributable To Noncontrolling Interest |
43.29%
-0.0735
|
-0.1297 | -0.2495 | -0.041 | -0.0758 |
| Basic Average Shares |
2.40%
26.06
|
25.45 | 1.5415 | 23.26 | 17.39 |
| Diluted Average Shares |
2.40%
26.06
|
25.45 | 1.5415 | 23.26 | 17.39 |
| Basic Earnings Per Share |
50.00%
-0.03
|
-0.06 | -0.16 | -0.09 | -0.13 |
| Diluted Earnings Per Share |
50.00%
-0.03
|
-0.06 | -0.16 | -0.09 | -0.13 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):